SCHEMBL15217772

SCHEMBL15217772

CCNC1CCP(=O)(c2ccc(N)c(OC)c2)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.38
CYP3A4 P08684 2/20 0.38
HTT P42858 2/20 0.38
TDP1 Q9NUW8 3/20 0.36
DRD2 P14416 1/20 0.36
DRD4 P21917 1/20 0.36
DRD3 P35462 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
HTR4 Q13639 6/20 0.35
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
ADRA2C P18825 1/20 0.33
CHRM3 P20309 1/20 0.33
HTR1D P28221 1/20 0.33
ADRA1B P35368 1/20 0.33
HTR2B P41595 1/20 0.33
HTR3A P46098 1/20 0.33
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15217774 0.84 ALDH1A1 (0.41) ALDH1A1CYP3A4HTTTDP1TSHR
SCHEMBL30184542 0.78 ALDH1A1 (0.49) ALDH1A1CYP3A4HTTTDP1TSHR
SCHEMBL10182161 0.77 CFTR (0.40) DRD2HTR4KMT2A
SCHEMBL11916218 0.77 ALDH1A1 (0.47) ALDH1A1CYP3A4HTTTDP1TSHR
SCHEMBL13619289 0.76 ALDH1A1 (0.46) ALDH1A1CYP3A4HTTTDP1TSHR
SCHEMBL11900225 0.75 ALDH1A1 (0.41) ALDH1A1CYP3A4HTTTDP1TSHR
SCHEMBL22232917 0.74 ALDH1A1 (0.40) ALDH1A1CYP3A4HTTTDP1TSHR
SCHEMBL15600809 0.73 ALDH1A1 (0.44) ALDH1A1CYP3A4HTTTDP1TSHR
SCHEMBL517526 0.73 TP53 (0.37) ALDH1A1CYP3A4HTTTDP1TSHR
SCHEMBL21938970 0.71 HTR4 (0.36) ALDH1A1CYP3A4HTTTDP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130225528-A1 Phosphorus Derivatives as Kinase Inhibitors ARIAD PHARMACEUTICALS, INC. (US) 2013-08-29 US disclosed
US-20130225528-A1 Phosphorus Derivatives as Kinase Inhibitors ARIAD PHARMACEUTICALS, INC. (US) 2013-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130225528-A1 Phosphorus Derivatives as Kinase Inhibitors PHKA1, PIK3CA, PHKA2 ALDH1A1 4707/4885CYP3A4 2859/4885HTT 4879/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.